SG

Swapnali Goswami

Active Director Director DIN 09734470
DIN 09734470 First appointment Sep 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Swapnali Goswami

Data last updated:

Swapnali Goswami is a Director at Minzel Pharmaceutical Private Limited (since 2022). The company operates in Pharma.

DIN 09734470
Primary Designation Director
Industry Pharma
First Appointment 15 Sep 2022
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Sep 20222021Active

Directorship timeline

Open interactive timeline →
Minzel Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Swapnali Goswami

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swapnali Goswami

Swapnali Goswami currently holds 1 directorship: Minzel Pharmaceutical Private Limited (Director, since 15 Sep 2022).

Swapnali Goswami was first appointed on 15 Sep 2022 as Director at Minzel Pharmaceutical Private Limited.

The current boards of Swapnali Goswami's companies include Deepika Sinha Patel (Minzel Pharmaceutical Private Limited), Ratul Ali (Minzel Pharmaceutical Private Limited), Ratul Ali (Minzel Pharmaceutical Private Limited), Ratul Bora (Minzel Pharmaceutical Private Limited), Syed Mahfuz Alam (Minzel Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available